Price Alert

Eledon Pharmaceuticals In... (ELDN)

NASDAQ: ELDN · Real-Time Price · USD

2.63

0.03 (1.15%)

At close: Aug 15, 2025, 3:59 PM

2.63

0.19%

After-hours: Aug 15, 2025, 07:54 PM EDT

Eledon Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	8.5M	20.55M	6.75M	26.04M	5.66M	4.61M	3.67M	40.95M	46.48M	56.41M	65.89M	70.46M	76.68M	84.83M	94.04M	101.13M	108.58M
Short-Term Investments	116.39M	119.63M	71.44M	57.57M	37.21M	46.49M	55.94M	30.43M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	354K	363K	210K	255K	185K	186K	233K	224K	369K	150K	155K	303K	344K	400K	356K	422K	315K
Receivables	761K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	87K	197K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.35M	-197K
Other Current Assets	55K	729K	442K	157K	54K	90K	90K	238K	47K	28K	57K	32K	17K	34K	11K	11K	26K
Total Current Assets	127.72M	143.73M	81.51M	87.22M	47.98M	56.13M	62.99M	73.62M	48.9M	59.52M	67.56M	72.79M	79.33M	88.35M	95.56M	102.58M	110.24M
Property-Plant & Equipment	850K	926K	471K	621K	270K	365K	459K	553K	647K	739K	832K	581K	675K	768K	222K	267K	92K
Goodwill & Intangibles	32.39M	32.39M	32.39M	32.39M	32.39M	32.39M	32.39M	32.39M	32.39M	32.39M	81.03M	81.03M	81.03M	81.03M	81.03M	81.03M	81.03M
Total Long-Term Assets	33.59M	33.67M	33.07M	33.26M	32.84M	69.77M	33.08M	33.16M	33.4M	33.27M	82.02M	81.92M	82.05M	82.2M	81.61M	81.72M	81.44M
Total Assets	161.31M	177.41M	114.58M	120.48M	80.82M	125.89M	96.07M	106.78M	82.31M	92.79M	149.59M	154.71M	161.38M	170.55M	177.17M	184.31M	191.68M
Account Payables	2.9M	5.83M	5.86M	2.15M	1.86M	967K	465K	2.2M	2.85M	2.2M	3.86M	1.32M	1.03M	1.81M	1.6M	857K	1.51M
Deferred Revenue	n/a	n/a	n/a	217K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	314K	n/a	269K	284K	383K	396K	390K	384K	363K	378K	287K	328K	369K	177K	179K	97K
Other Current Liabilities	1.32M	3.83M	2.06M	1.78M	846K	1.62M	1.15M	1.03M	1.01M	1.64M	903K	774K	486K	1.15M	1.31M	806K	1.66M
Total Current Liabilities	9.19M	11.58M	12.49M	6.03M	4.25M	3.9M	2.9M	4.9M	5.48M	6.47M	6.28M	3.28M	2.96M	4.4M	4.05M	2.68M	4.21M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	34.8M	44.87M	23.96M	120.82M	n/a	36.83M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	37.54M	47.69M	26.03M	122.96M	1.75M	38.58M	1.83M	1.94M	2.04M	2.13M	2.21M	2.05M	2.1M	2.15M	2.38M	3.11M	3.6M
Total Liabilities	46.73M	59.27M	38.52M	128.98M	6M	42.48M	4.73M	6.84M	7.51M	8.61M	8.49M	5.33M	5.06M	6.55M	6.42M	5.78M	7.81M
Total Debt	880K	954K	501K	655K	284K	383K	479K	574K	668K	746K	839K	586K	678K	769K	222K	269K	97K
Common Stock	60K	60K	41K	39K	25K	24K	24K	23K	14K	14K	14K	14K	14K	14K	14K	14K	14K
Retained Earnings	-362.08M	-355.59M	-310.97M	-387.94M	-253.49M	-243.19M	-233.56M	-223.22M	-213.64M	-202.87M	-144.48M	-134.01M	-124.76M	-114.9M	-106.09M	-96.28M	-88.89M
Comprehensive Income	-18K	26K	102K	n/a	n/a	-0.00	n/a	n/a	n/a	0.00	-0.00	-0.00	n/a	n/a	-0.00	-0.00	-0.00
Shareholders Equity	114.58M	118.14M	76.06M	-8.5M	74.82M	83.42M	91.33M	99.95M	74.79M	84.18M	141.09M	149.38M	156.32M	164M	170.75M	178.52M	183.87M
Total Investments	116.39M	119.63M	71.44M	57.57M	37.21M	46.49M	55.94M	30.43M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a